In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke

Ann Intern Med. 2022 Mar 1. doi: 10.7326/J22-0008. Online ahead of print.ABSTRACTWang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021;385:2520-30. 34708996.PMID:35226525 | DOI:10.7326/J22-0008

Source: Annals of Internal Medicine - February 28, 2022 Category: Internal Medicine Authors: Raed A Joundi Source Type: research